E. Eigendorff

机构：Zentralklinik Bad Berka

发表论文 23 篇 · 总被引 1959 次 · h-index 10

代表论文

• Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer (2023 · New England Journal of Medicine · 被引 1142)
• Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial (2024 · The Lancet · 被引 298)
• Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial (2018 · The Lancet Oncology · 被引 164)
• 11β-Hydroxysteroid Dehydrogenase Types 1 and 2: An Important Pharmacokinetic Determinant for the Activity of Synthetic Mineralo- and Glucocorticoids (2002 · The Journal of Clinical Endocrinology & Metabolism · 被引 153)
• LBA56 Overall survival in the KEYNOTE-671 study of perioperative pembrolizumab for early-stage non-small-cell lung cancer (NSCLC) (2023 · Annals of Oncology · 被引 84)
• 1235TiP Perioperative pembrolizumab + platinum-based chemotherapy for resectable locally advanced non-small cell lung cancer: The phase III KEYNOTE-671 study (2020 · Annals of Oncology · 被引 26)